Peter Simons

"Even with preregistration requirements there is a stock of existing drugs potentially based on biased evidence," Oostrom writes.

Those who partook in mindfulness, stress management, well-being apps, and more were no better off than those who avoided them.

About two-thirds of peer reviewers in psychiatry/neurology received payments from the pharma/device industry.

The label made people think you need professional help, need special help with your life activities, and had less control over your behavior/emotions. It may have also increased empathy—but this finding wasn’t consistent.

Although some results faded after 16 weeks, improvements in personal recovery, well-being, and more were all in favor of dialogic AVATAR therapy.

87% of involuntary hospitalization applications didn't include a clinical workup, the majority were Black, 17% did not have a listed psychiatric diagnosis, and 27% were not considered a danger to self or others.

Researchers expose how regulatory bodies approve psychedelic drugs for psychiatric use despite poor quality evidence riddled with biases.

The drugs, especially benzos and high doses of antipsychotics, led to an increased risk of death within five years. Antidepressants also did not reduce mortality.

A new meta-analysis finds no evidence that psychiatric drugs effectively treat chronic pain in the long term, while highlighting serious potential harms like deadly falls in older adults.

Researchers say the science confirms “the relative ineffectiveness” of existing therapy treatments and propose policy change to address the societal ills that cause distress.